Memorial Sloan-Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our list of clinical trials that are currently enrolling new pediatric patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.
Title |
Investigator | Disease(s) |
|---|---|---|
|
Treatment of Patients with Newly Diagnosed Standard Risk B-precursor Acute Lymphoblastic Leukemia [Protocol 11-002] |
Shukla, Neerav |
|
|
Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors [Protocol 12-114] |
Kobos, Rachel |
|
|
Treatment of Children with All Stages of Hepatoblastoma [Protocol 10-046] |
Kobos, Rachel |
|
|
Treatment of Atypical Teratoid/Rhabdoid Tumors of the Central Nervous System with Surgery, Intensive Chemotherapy, and 3-D Conformal Radiation [Protocol 09-070] |
Dunkel, Ira |
|
|
Treatment for Very Low-Risk and Standard-Risk Favorable Histology Wilms Tumor [Protocol 12-084] |
Kobos, Rachel |
|
|
Transplantation of Unrelated Donor Double-Unit Cord Blood with T-Cell-Depleted Stem Cells for Patients with High-Risk Hematologic Cancers [Protocol 12-153] |
Barker, Juliet |
|
|
Renal Tumor Classification, Biology, and Banking Study [Protocol 12-014] |
Kobos, Rachel |
|
|
Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children with Cancer (ALTE07C1) [Protocol 12-241] |
Dunkel, Ira |
|
|
Molecular Characterization of Neuroblastic Tumors and Clinical Outcome [Protocol 00-109] |
Cheung, Nai-Kong |
|
|
High-Dose Chemotherapy with Autologous Stem Cell Rescue for Aggressive B-Cell Lymphoma and Hodgkin Lymphoma in HIV-infected Patients [Protocol 10-181] |
Noy, Ariela |
|
|
Hereditary Colorectal Cancer Family Registry [Protocol 01-110] |
Guillem, Jose |
|
|
Heart-Sparing Whole Lung IMRT in Children and Young Adults with Lung Metastases: A Feasibility Study [Protocol 11-100] |
Wolden, Suzanne |
|
|
Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Cancer and Bone Marrow Transplantation Patients [Protocol 03-123] |
Meyers, Paul |
|
|
Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation from HLA-Compatible Unrelated Donors in Severe Aplastic Anemia [Protocol 06-056] |
Castro-Malaspina, Hugo |
|
|
Expanded Access of Prochymal Infusion for the Treatment of Pediatric Patients with Acute Refractory GVHD [Protocol 09-072] |
Prockop, Susan |
|
|
Evaluating the Causes of Cancer in Young Patients [Protocol 09-068] |
Stadler, Zsofia |
|
|
Early Onset and Familial Gastric Cancer Registry [Protocol 05-118] |
Kelsen, David |
|
|
Defibrotide for Patients with Hepatic Veno-Occlusive Disease [Protocol 08-060] |
Kernan, Nancy |
|
|
Cyclophosphamide, Fludarabine, and Total Body Irradiation Followed by the Transplantation of Unrelated Double-Unit Donor Umbilical Cord Blood Grafts for Patients with Hematological Malignancy [Protocol 06-014] |
Barker, Juliet |
|
|
Brentuximab (SGN-35) in Transplant-Eligible Patients with Relapsed or Refractory Hodgkin Lymphoma [Protocol 11-142] |
Moskowitz, Alison |
|
